Cost-Effectiveness Analysis of 4 Kinds of Chinese Patent Drugs for Hepatic Fibrosis / 中国药房

OBJECTIVE:To analyze the cost-effectiveness of 4 kinds of Chinese patent drugs in the treatment of hepatic fibrosis. METHODS:84 patients with hepatic fibrosis were treated with Dahuang Zhechong capsule(group A) ,Fuzheng Huayu capsule(group B) ,Fufang Biejia Ruangan tablet(group C) and Biejia Jian pill(group D) ,respectively. Then cost-effectiveness was analyzed with pharmacoeconomic method. RESULTS:The total costs(C) were 835.2 yuan for group A,1228.5 yuan for group B,1922.4 yuan for group C and 488 yuan for group D. The total effective rates(E) were 76.19%,80.95%,85.71%,80.95%,respectively(P